别名:F8; F8C; Coagulation factor VIII; Antihemophilic factor; AHF; Procoagulant component应用:WB,IHC
反应种属:Human,Mouse
规格:50μl/100μl
| Description |
|---|
| F8: coagulation factor VIII, procoagulant component. This gene encodes coagulation factor VIII, which participates in the intrinsic pathway of blood coagulation; factor VIII is a cofactor for factor IXa which, in the presence of Ca+2 and phospholipids, converts factor X to the activated form Xa. This gene produces two alternatively spliced transcripts. Transcript variant 1 encodes a large glycoprotein, isoform a, which circulates in plasma and associates with von Willebrand factor in a noncovalent complex. This protein undergoes multiple cleavage events. Transcript variant 2 encodes a putative small protein, isoform b, which consists primarily of the phospholipid binding domain of factor VIIIc. This binding domain is essential for coagulant activity. Defects in this gene results in hemophilia A, a common recessive X-linked coagulation disorder. |
| Specification | |
|---|---|
| Aliases | F8; F8C; Coagulation factor VIII; Antihemophilic factor; AHF; Procoagulant component |
| Entrez GeneID | 2157 |
| Swissprot | P00451 |
| WB Predicted band size | Calculated MW: 267 kDa; Observed MW: 300 kDa |
| Host/Isotype | Rabbit IgG |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse |
| Immunogen | Synthesized peptide derived from the C-terminal region of human Factor VIII. at AA rangle: 2130-2210 |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3. |
| Application | |
|---|---|
| WB | 1/500-1/1000 |
| IHC | 1/50-1/100 |
| ELISA | 1/10000 |
![]() |
Western blot analysis of Factor VIII in HuvEc lysates using Factor VIII antibody. |
![]() |
Western blot analysis of Factor VIII in HuvEc lysates using Factor VIII antibody. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的,不可用于人类或动物的临床诊断或治疗,非药用,非食用。
中文


发表回复